Why IXHL? Incannex Healthcare Inc. Analysis, Price & AI Insights | Whystock
IXHL
$4.55+0.16 (+3.64%)
Market ClosedLast close May 1
Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia.